News | May 09, 2024
Vijaya Diagnostic Centre posts Q4 FY24 consolidated PAT at Rs. 33.45 Cr
The company has posted net profit of Rs.118.82 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.118.82 crores for the Financial Year ended March 31, 2024
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
The surgeons were able to remove the entire breast while preserving the nipple through tiny hidden incisions
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
Launch of Indian public health standards for Ayush healthcare facilities
_in_Mizushima,_Japan_256_384.jpg)
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
The CDCCs are strategically positioned in regions identified as high-impact areas
Subscribe To Our Newsletter & Stay Updated
